NIH-funded research NIH-funded research

Developing models to understand infectious diseases.

Official title: Pre-Clinical Models of Infectious Diseases

Funded at University of Saskatchewan · NIH-11197707 · Data updated 2026-11-12

This study is working on building models that mimic infectious diseases to help scientists learn how they work and find better treatments, which could lead to improved options for patients dealing with these illnesses.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Saskatchewan
NIH-funded
Lab location1 site (Saskatoon, Canada)
Project startJuly 15, 2024
Project endJuly 14, 2031
Funding year2024
Award (this year)$2,500
NIH project number75N93024D00040-0-759302400003-1
Project IDNIH-11197707 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit would include individuals at risk of infectious diseases or those who may require new treatment options.

Less likely to help

Patients with non-infectious diseases or those who do not respond to current treatments may not receive benefit from this research.

What this research studies

This research focuses on creating pre-clinical models that simulate infectious diseases to better understand their mechanisms and potential treatments. By using these models, researchers aim to evaluate the effectiveness of medical countermeasures against various infectious agents. Patients may benefit from advancements in treatment options that arise from the insights gained through these models, which could lead to more effective therapies and preventive measures.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments and preventive strategies for infectious diseases.

How similar studies have gone: Other research has shown success in using pre-clinical models to advance understanding and treatment of infectious diseases, indicating this approach is well-established.

Where this research is happening

  • University of Saskatchewan
    Saskatoon, Canada
    Active

Related research

Other NIH-funded projects on the same topics.

  • Developing models to understand infectious diseases.

    This study is all about building models that mimic infectious diseases so researchers can learn how they work and find better treatments, which could help patients like you in the future.

    NIH research University of Saskatchewan · Saskatoon, Canada · NIH-11197697

  • Developing models to understand infectious diseases.

    This study is all about building models that mimic infectious diseases so researchers can learn how they work and find better treatments, which could help patients like you in the future.

    NIH research University of Saskatchewan · Saskatoon, Canada · NIH-11197689

  • Developing new biopharmaceutical products for infectious diseases

    This study is working on improving the way new medicines, like antibodies and proteins, are developed to help treat infectious diseases, so that patients can have better and more effective treatment options.

    NIH research University of Saskatchewan · Saskatoon, Canada · NIH-10934791

  • Developing new treatments to combat bacterial resistance using biopharmaceuticals

    This study is working on new treatments to help fight stubborn bacterial infections that don't respond to regular antibiotics, so patients can have better options for getting better.

    NIH research University of Saskatchewan · Saskatoon, Canada · NIH-10934790

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.